CTSH vs PROK · P/E 12, rev $21.11B vs rev $376.0K
Cognizant Technology Solutions Corp Class A (CTSH) versus ProKidney Corp. (PROK) — a side-by-side from cached financials, not a winner call.
Cognizant Technology Solutions Corp Class A (CTSH) is a information technology services company listed on US.
ProKidney Corp. (PROK) is a biotechnology company listed on US.
Latest reported CTSH revenue for 2025-12-31 was $21.11B. Net income was $2.23B. Revenue was up 7.0% from 2024-12-31 to 2025-12-31. CTSH currently screens at market cap $25.17B and trailing P/E 11.5.
Latest reported PROK revenue for 2026-06-30 was $376.0K. Net income was -$48.5M. Revenue was up 66.4% from 2026-03-31 to 2026-06-30. PROK currently screens at market cap $543.7M.
CTSH currently screens at market cap $25.17B and trailing P/E 11.5. PROK currently screens at market cap $543.7M.
Not investment advice. Open the CTSH and PROK stock pages for the full models.
Not investment advice.